Patents for A61P 27 - Drugs for disorders of the senses (53,017)
09/2011
09/28/2011CN102198258A Method for preparing Chinese medicine for treating kidney-yin deficiency tympanitis
09/28/2011CN102198232A Method for preparing Chinese medicine for treating suppurative otitis media
09/28/2011CN102198227A Method for preparing Chinese medicine for treating yin-deficiency glaucoma
09/28/2011CN102198193A Method for preparing Chinese medicine for treating wind- and fire-rooted glaucoma
09/28/2011CN102198093A Tosufloxacin tosylate eye drop and preparation method thereof
09/28/2011CN102198087A Preservative-free ophthalmic in-situ gelling agent and preparation method thereof
09/28/2011CN101891738B Dasatinib polymorph and preparation method and medical composition thereof
09/28/2011CN101780105B Eye drop of deproteinized calf blood extractive
09/28/2011CN101732238B 丝裂霉素c眼用凝胶剂 Mitomycin c eye gel
09/28/2011CN101669996B Method for preparing vision-health buccal tablet
09/28/2011CN101632646B Olopatadine hydrochloride tablet as well as preparation method and detecting method thereof
09/28/2011CN101564494B Use of traditional Chinese composition
09/28/2011CN101439152B Chinese medicinal composition for treating cataract as well as preparation method
09/28/2011CN101293056B Medicament for preventing and treating near-sightedness
09/27/2011US8026273 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
09/27/2011US8026240 Octahydro-pyrrolo[3,4-b]pyrrole N-oxides
09/27/2011US8026231 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof
09/27/2011US8025883 Antagonists and methods for inhibiting angiogenesis
09/27/2011CA2506476C Method of treatment of myocardial infarction
09/27/2011CA2475930C 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
09/27/2011CA2440630C Metalloproteinase inhibitors
09/27/2011CA2440042C Carboxamide derivatives as therapeutic agents
09/27/2011CA2400462C Aspirin-triggered lipid mediators
09/27/2011CA2336218C Neurotrophic factors
09/22/2011WO2011116292A1 Combination compositions of adenosine a1 agonists and non-selective beta-adrenergic receptor blockers for reducing intraocular pressure
09/22/2011WO2011116290A1 Combination compositions of adenosine a1 agonists and carbonic anhydrase inhibitors for reducing intraocular pressure
09/22/2011WO2011116123A1 Tafamidis for the treatment of ophthalmic diseases
09/22/2011WO2011116020A2 Ophthalmic formulations of cetirizine and methods of use
09/22/2011WO2011115183A1 Novel monocyclic pyrimidine derivative
09/22/2011WO2011115173A1 Monomaleate of benzothiazine compound
09/22/2011WO2011114645A1 Anti-allergic composition
09/22/2011WO2011114071A2 Synthetic cyclopeptide, preparation process and uses
09/22/2011WO2011113904A1 Medicaments for the prevention and treatment of a disease associated with retinal ganglion cell degeneration
09/22/2011WO2011113855A2 Pharmaceutical composition for treatment of increased intraocular pressure
09/22/2011WO2011063178A3 Intravenous infusion of curcumin and a calcium channel blocker
09/22/2011US20110230556 Diglycidic Ether Derivative Therapeutics and Methods for Their Use
09/22/2011US20110230544 Modulation of c-reactive protein expression
09/22/2011US20110230539 Small Molecule Inhibitors of N-Terminus Activation of the Androgen Receptor
09/22/2011US20110230502 Modulation of chemosensory receptors and ligands associated therewith
09/22/2011US20110230470 Substituted pyrazolo[4,3-c]pyridine derivatives active as kinase inhibitors
09/22/2011US20110230440 Inhibitors of fatty acid amide hydrolase
09/22/2011US20110230424 Ophthalmic solutions, including contact lens care and eye drops comprising carnosine, preferably in combination with dexpanthenol and/or hyaluronic acid
09/22/2011US20110230415 Pharmaceutical Composition Containing GHRP-6 To Prevent And Eliminate Fibrosis And Other Pathological Deposits In Tissues
09/22/2011US20110230410 LOW DENSITY LIPOPROTEIN RECEPTOR-MEDIATED siRNA DELIVERY
09/22/2011US20110230397 Peptides having pharmacological activity for treating disorders associated with altered cell migration, such as cancer
09/22/2011US20110229944 FAD4, FAD5, FAD5-2, AND FAD6, Novel Fatty Acid Desaturase Family Members and Uses Thereof
09/22/2011US20110229557 Methods for treating eye disorders
09/22/2011US20110229551 Drug delivery compositions and methods using nanofiber webs
09/22/2011US20110229466 Vascular endothelial growth factor 2
09/22/2011US20110229464 Pharmaceutical compositions and methods for treating age-related macular degeneration with melatonin analogues
09/22/2011US20110229457 Injectable drug delivery system
09/22/2011US20110229452 Ophthalmic Surgical Irrigating Solutions Containing Hyaluronidase
09/22/2011US20110229449 Prophylaxis and treatment of macular degeneration and retinopathy using a prdx protein
09/22/2011US20110229439 Complement proteins
09/22/2011US20110226650 Antibody formulation
09/22/2011CA2788060A1 Pharmaceutical composition for treatment of increased intraocular pressure
09/21/2011EP2366389A1 Severe sepsis preventive therapeutic agent
09/21/2011EP1616577B1 2-chloro-6,7-dimethoxy-N-5 [5-(1)H- indazolyl]quinazoline-4-amine, N-(1-benzyl-4-piperidinyl)-1H-indazole-5-amine dihydrochloride, 4-[2-(2,3,4,5,6-pentafluorophenyl)acryloyl]cinnamic acid and fasudil hydrochloride for use in repairing corneal perception.
09/21/2011EP1581047B1 Radiopaque animal chew
09/21/2011EP1471926B8 Compositions and methods for the therapeutic use of an atonal-associated sequence
09/21/2011EP1341546B1 Kyberdrug as autovaccines with immune-regulating effects
09/21/2011CN201978189U 护眼贴 Eye stickers
09/21/2011CN1864434B Wireless microphone communication system
09/21/2011CN102197023A Compounds for treating ophthalmic diseases and disorders
09/21/2011CN102196733A Method for concentrating lipid
09/21/2011CN102190727A Monoclonal antibody, composition taking same as active ingredient, and application of monoclonal antibody
09/21/2011CN102190633A Cetirizine derivatives, and composition and application thereof
09/21/2011CN102188705A Medicament composition containing bis cyclooctane derivatives
09/21/2011CN102188695A Ophthalmic gel composition
09/21/2011CN102188683A Preparation method of traditional Chinese medicine for treating otitis media with nasal swelling
09/21/2011CN102188675A Medicine for treating peripheral vertigo, and preparation thereof
09/21/2011CN102188637A Traditional Chinese drug composition for treating macular degeneration, and preparation method thereof
09/21/2011CN102188604A Medicament for treating myopia and presbyopia
09/21/2011CN102188596A Method for preparing Chinese medicine for treating toxic heat tympanitis
09/21/2011CN102188584A Traditional Chinese medicine composition for treating glaucoma
09/21/2011CN102188558A Method for preparing traditional Chinese medicine for treating pharyngalgia otitis media
09/21/2011CN102188557A Application of Juncus effuses L. extract in preparing anti-tumor or angiogenesis-inhibiting medicament, health food or cosmetic
09/21/2011CN102188542A Medicament for treating tinnitus and preparation method thereof
09/21/2011CN102188523A Plant antibiotic
09/21/2011CN102188454A Externally-applied medicinal liquor for treating earache and preparation method thereof
09/21/2011CN102188450A Preparation method of pearl liquid
09/21/2011CN102188412A Selegiline-containing adhesive preparation
09/21/2011CN102188411A Selegiline-containing adhesive preparation
09/21/2011CN102188368A Preparation technology of compound sodium chloride eye drop solution
09/21/2011CN102188132A Myopia health care traditional Chinese medicinal pillow
09/21/2011CN101461906B Health product with function for removing liver-fire and improving eyesight as well as preparation method thereof
09/21/2011CN101365430B Adenosine a3 receptor agonists for the treatment of dry eye disorders
09/21/2011CN101242818B Use of a combination comprising L-carnitine or alkanoyl L-carnitine, lipid solubl benzoquinone and omega-3-polyunsaturated fatty acid for the preparation of a dietary supplement or medicament for the
09/21/2011CN101199685B Smoked washing medicament for treating chronicity conjunctivitis
09/20/2011US8022176 FAS peptide mimetics and uses thereof
09/20/2011US8022041 Prodrug of an ICE inhibitor
09/20/2011US8021693 Methods of organ regeneration using Hox11-expressing pluripotent cells
09/20/2011CA2470102C Novel combination containing a poloxamer and chondroitin sulphuric acid and/or a glycoprotein and use thereof
09/20/2011CA2462903C Beta-lactamyl vasopressin v1a antagonists
09/20/2011CA2377977C Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes
09/19/2011DE202010009243U1 Zubereitung Preparation
09/16/2011CA2708068A1 Hydrolyzed type i collagen composition and use for treatment of ocular tissue
09/15/2011WO2011113065A2 Pegylated polyplexes for polynucleotide delivery
09/15/2011WO2011112679A1 Synthesis of alpha-tocopherolquinone derivatives, and methods of using the same
09/15/2011WO2011112243A2 Beta -adrenergic receptor agonists and uses thereof
1 ... 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 ... 531